Flow Cytometric Analysis of Cellular DNA Content as An Adjunct to the Diagnosis of Ovarian Tumours of Borderline Malignancy

References

• Russell P, Merkur H. Proliferating ovarian “epithelial” tumours: A clinico-pathological analysis of 144 cases. Aust NZ J Obstet Gynaecol 1979; 19: 45–51
   PubMedGoogle Scholar
• Hart W R. Ovarian epithelial tumours of borderline malignancy (carcinomas of low malignant potential). Hum Pathol 1977; 8: 541–9
   PubMedGoogle Scholar
• Scully R E. Tumors of the ovary and maldeveloped gonads (AFIP Fascicle 16, Second Series). Armed Force Institute of Pathology, Washington 1979; 53–151
   Google Scholar
• Russell P. The pathological assessment of ovarian neoplasms. II: The proliferating ‘epithelial’ tumours. Pathology 1979; 11: 251–82
   PubMed Web of Science ®Google Scholar
• Friedlander M L, Hedley D W, Taylow I W, et al. The influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 1984; 44: 397–400
   PubMed Web of Science ®Google Scholar
• Serov S F, Scully R E. Histological Typing of Ovarian Tumours (International Histological Classification of Tumours No. 9). World Health Organisation, Geneva 1973
   Google Scholar
• Taylor L W. A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem 1980; 28: 1021–4
   PubMed Web of Science ®Google Scholar
• Hedley D W, Friedlander M L, Taylor I W, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–5
   PubMed Web of Science ®Google Scholar
• Taylor I W, Milthorpe B K. An evaluation of DNA fluorochromes, staining techniques and analysis for flow cytometry. J Histochem Cytochem 1980; 28: 1224–32
   PubMed Web of Science ®Google Scholar
• Friedlander M L, Taylor I W, Russell P, et al. Ploidy as a prognostic factor in ovarian cancer. Int J Gynacol Pathol 1983; 2: 55–63
   PubMed Web of Science ®Google Scholar
• Barlogie B, Drewinko B, Schumann J, et al. Cellular DNA content as a marker of neoplasia in man. Am J Med 1980; 69: 195–203
   PubMed Web of Science ®Google Scholar
• Tribukait B, Gustafson H, Esposti P L. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: A study of 100 untreated cases. Br J Urol 1982; 54: 130–5
   PubMedGoogle Scholar
• Taylor I W, Musgrove E A, Friedlander M L, et al. The influence of age on DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol 1983; 19: 623–8
   PubMedGoogle Scholar
• Olszewski W, Darzynskiewicz Z, Claps M L, Melamed M R. Flow cytometry of lung carcinoma. A comparison of DNA stem line and cell cycle distribution with histology. Anal Quant Cytol 1982; 25: 90–4
   Google Scholar
• Sondergaard K, Larsen J K, Moller U, et al. DNA ploidy characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course. Virchows Arch (Cell Pathol) 1983; 42: 43–52
   Google Scholar
• Tribukait B, Hammarberg C, Rubio C. Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes classification and histopathological differentiation. Acta Pathol Microbiol Scand [A] 1983; 91: 89–95
   Google Scholar
• Perez D J, Taylor I W, Milthorpe B K, et al. Identification and quantitation of tumour cells in cell suspensions: A comparison of cytology and flow cytometry. Br J Cancer 1981; 43: 526–31
   PubMed Web of Science ®Google Scholar
• Rognum T O, Thorud E, Elgo K, et al. Large bowel carcinomas with different ploidy related to secretory component, IgA and CEA in epithelium and plasma. Br J Cancer 1982; 45: 921–34
   PubMed Web of Science ®Google Scholar
• Russel P. Borderline epithelial tumours of the ovary: A conceptual dilemma. Clinics in Obstet Gynaecol 1984; 11: 259–77
   Google Scholar
• Fox H, Langley F A. Tumours of the Ovary. Heinemann, London 1976; 74–118
   Google Scholar
• Baak J PA, Agrafojo B A, Jurver P HI, et al. Quantitative analysis of borderline and malignant mucinous ovarian tumours. Histopathology 1981; 5: 353–60
   Google Scholar
• Bunn P A, Krasnow S, Nakuch R W, et al. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: Clinical implications. Blood 1982; 59: 528–35
   PubMed Web of Science ®Google Scholar
• Wolley R C, Schreiber K, Koss L G, et al. DNA distribution in human colonic carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 1982; 69: 15–22
   PubMedGoogle Scholar
• Barlogie B, Johnston D A, Smallwood L, et al. Prognostic implications of ploidy and proliferative activity in human solid tumors. Cancer Genet Cytogenet 1982; 6: 17–28
   PubMedGoogle Scholar
• Hart W R, Usar M C, Norris H J. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behaviour. Cancer 1973; 31: 1031–45
   PubMed Web of Science ®Google Scholar
• Weiss R R, Richart R M, Okagarki T. DNA content of mucinous tumours of the ovary. Am J Obstet Gynecol 1969; 103: 409–24
   Google Scholar
• Friedlander M L, Taylor I W, Russell P, Tattersall M HN. Cellular DNA content: A stable marker in ovarian cancer. Brit J Cancer 1984; 49: 173–9
   PubMed Web of Science ®Google Scholar